Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Previous Next 		Contents: Volume 20, Number 4, April 2009   [Index by Author] 

Down in this issue
Down editorial
Down reviews
Down original articles
     breast cancer
     gynecologic tumors
     gastrointestinal tumors
     lung cancer
     urogenital tumors
     hematologic malignancies
     quality of life
     supportive care
     phase I and pharmacokinetics
     epidemiology
     sarcomas
Down letters to the editor


[Search ALL Issues]

Front Matter (PDF) | Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

in this issue Back

in this issue
Ann Oncol 2009 20: 603; doi:10.1093/annonc/mdp205 [Extract] [Full Text] [PDF] [Request Permissions]  

editorial Back

R. Wong and D. Cunningham
Optimising treatment regimens for the management of advanced gastric cancer
Ann Oncol 2009 20: 605-608; doi:10.1093/annonc/mdp203 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews Back

J. Fasano and F. Muggia
Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 609-614; doi:10.1093/annonc/mdn669 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

C. Falandry, P. A. Canney, G. Freyer, and L. Y. Dirix
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
Annals of Oncology Advance Access published on March 2, 2009
Ann Oncol 2009 20: 615-620; doi:10.1093/annonc/mdn693 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles Back

breast cancer Back

S. Dawood, K. Broglio, F. J. Esteva, W. Yang, S.-W. Kau, R. Islam, C. Albarracin, T. K. Yu, M. Green, G. N. Hortobagyi, and A. M. Gonzalez-Angulo
Survival among women with triple receptor-negative breast cancer and brain metastases
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 621-627; doi:10.1093/annonc/mdn682 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. Spitale, P. Mazzola, D. Soldini, L. Mazzucchelli, and A. Bordoni
Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland
Annals of Oncology Advance Access published on December 12, 2008
Ann Oncol 2009 20: 628-635; doi:10.1093/annonc/mdn675 [Abstract] [Full Text] [PDF] [Request Permissions]  

H.-G. Moon, W. Han, J. W. Lee, E. Ko, E.-K. Kim, J.-H. Yu, S. Y. Kang, W. K. Moon, N. Cho, I.-A. Park, D.-Y. Oh, S.-W. Han, S.-A. Im, and D.-Y. Noh
Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 636-641; doi:10.1093/annonc/mdn683 [Abstract] [Full Text] [PDF] [Request Permissions]  

T. Li, P. J. Christos, J. A. Sparano, D. L. Hershman, S. Hoschander, K. O'Brien, J. J. Wright, and L. T. Vahdat
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 642-647; doi:10.1093/annonc/mdn689 [Abstract] [Full Text] [PDF] [Request Permissions]  

S. Gori, A. Sidoni, M. Colozza, I. Ferri, M. G. Mameli, D. Fenocchio, L. Stocchi, J. Foglietta, V. Ludovini, E. Minenza, V. De Angelis, and L. Crinò
EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
Annals of Oncology Advance Access published on February 2, 2009
Ann Oncol 2009 20: 648-654; doi:10.1093/annonc/mdn681 [Abstract] [Full Text] [PDF] [Request Permissions]  

G. Mustacchi, M. Mansutti, C. Sacco, S. Barni, A. Farris, M. Cazzaniga, M. Cozzi, and C. Dellach
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 655-659; doi:10.1093/annonc/mdn687 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors Back

A. A. Lissoni, N. Colombo, A. Pellegrino, G. Parma, P. Zola, D. Katsaros, S. Chiari, A. Buda, F. Landoni, M. Peiretti, T. Dell'Anna, R. Fruscio, M. Signorelli, R. Grassi, I. Floriani, R. Fossati, V. Torri, and E. Rulli
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study
Annals of Oncology Advance Access published on January 30, 2009
Ann Oncol 2009 20: 660-665; doi:10.1093/annonc/mdn690 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors Back

Y.-K. Kang, W.-K. Kang, D.-B. Shin, J. Chen, J. Xiong, J. Wang, M. Lichinitser, Z. Guan, R. Khasanov, L. Zheng, M. Philco-Salas, T. Suarez, J. Santamaria, G. Forster, and P. I. McCloud
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 666-673; doi:10.1093/annonc/mdn717 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. Ychou, J.-L. Raoul, J.-Y. Douillard, S. Gourgou-Bourgade, R. Bugat, L. Mineur, F. Viret, Y. Becouarn, O. Bouché, E. Gamelin, M. Ducreux, T. Conroy, J.-F. Seitz, L. Bedenne, and A. Kramar
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 674-680; doi:10.1093/annonc/mdn680 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. J. Pouchet, N. Wong, G. Chong, M. J. Sheehan, G. Schneider, B. Rosen-Sheidley, W. Foulkes, and M. Tischkowitz
A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers
Annals of Oncology Advance Access published on January 22, 2009
Ann Oncol 2009 20: 681-688; doi:10.1093/annonc/mdn686 [Abstract] [Full Text] [PDF] [Request Permissions]  

lung cancer Back

S. E. Witta, R. Dziadziuszko, K. Yoshida, K. Hedman, M. Varella-Garcia, P. A. Bunn, Jr, and F. R. Hirsch
ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC)
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 689-695; doi:10.1093/annonc/mdn703 [Abstract] [Full Text] [PDF] [Request Permissions]  

C.-H. Gow, Y.-L. Chang, Y.-C. Hsu, M.-F. Tsai, C.-T. Wu, C.-J. Yu, C.-H. Yang, Y.-C. Lee, P.-C. Yang, and J.-Y. Shih
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
Annals of Oncology Advance Access published on December 16, 2008
Ann Oncol 2009 20: 696-702; doi:10.1093/annonc/mdn679 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors Back

Y. Loriot, C. Massard, M. Gross-Goupil, M. Di Palma, B. Escudier, A. Bossi, and K. Fizazi
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 703-708; doi:10.1093/annonc/mdn694 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies Back

B. Esmaeli, P. McLaughlin, B. Pro, F. Samaniego, I. Gayed, F. Hagemeister, J. Romaguera, F. Cabanillas, S. S. Neelapu, R. Banay, L. Fayad, M. Wayne Saville, and L. W. Kwak
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 709-714; doi:10.1093/annonc/mdn692 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. Suzumiya, K. Ohshima, K. Tamura, K. Karube, N. Uike, K. Tobinai, R. D. Gascoyne, J. M. Vose, J. O. Armitage, D. D. Weisenburger, and for the International Peripheral T-cell Lymphoma Project
The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 715-721; doi:10.1093/annonc/mdn696 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. Kornacker, J. Stumm, C. Pott, S. Dietrich, S. Süssmilch, M. Hensel, M. Nickelsen, M. Witzens-Harig, M. Kneba, N. Schmitz, A. D. Ho, and P. Dreger
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 722-728; doi:10.1093/annonc/mdn691 [Abstract] [Full Text] [PDF] [Request Permissions]  

quality of life Back

M. Costantini, C. Ripamonti, M. Beccaro, M. Montella, P. Borgia, C. Casella, and G. Miccinesi
Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients' life. Results of an Italian mortality follow-back survey
Annals of Oncology Advance Access published on January 22, 2009
Ann Oncol 2009 20: 729-735; doi:10.1093/annonc/mdn700 [Abstract] [Full Text] [PDF] [Request Permissions]  

supportive care Back

O. Mir, J. Alexandre, A. Tran, J.-P. Durand, G. Pons, J.-M. Treluyer, and F. Goldwasser
Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity
Annals of Oncology Advance Access published on February 17, 2009
Ann Oncol 2009 20: 736-740; doi:10.1093/annonc/mdn698 [Abstract] [Full Text] [PDF] [Request Permissions]  

phase I and pharmacokinetics Back

A. Perotti, C. Sessa, A. Mancuso, C. Noberasco, S. Cresta, A. Locatelli, M. L. Carcangiu, K. Passera, A. Braghetti, D. Scaramuzza, F. Zanaboni, A. Fasolo, G. Capri, M. Miani, W. P. Peters, and L. Gianni
Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours
Annals of Oncology Advance Access published on February 3, 2009
Ann Oncol 2009 20: 741-745; doi:10.1093/annonc/mdn695 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology Back

X.-R. Wang, Y.-L. Chiu, H. Qiu, J. S. K. Au, and I. T.-S. Yu
The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 746-751; doi:10.1093/annonc/mdn699 [Abstract] [Full Text] [PDF] [Request Permissions]  

V. Shih, J. Y. L. Chiang, and A. Chan
Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 752-757; doi:10.1093/annonc/mdn659 [Abstract] [Full Text] [PDF] [Request Permissions]  

L. Yang, J. Fujimoto, D. Qiu, and N. Sakamoto
Trends in cancer mortality in Japanese adolescents and young adults aged 15–29 years, 1970–2006
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 758-766; doi:10.1093/annonc/mdn664 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. Bosetti, F. Levi, J. Ferlay, F. Lucchini, E. Negri, and C. La Vecchia
The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe
Annals of Oncology Advance Access published on December 16, 2008
Ann Oncol 2009 20: 767-774; doi:10.1093/annonc/mdn673 [Abstract] [Full Text] [PDF] [Request Permissions]  

T. Powles, J. Stebbing, A. Bazeos, E. Hatzimichael, S. Mandalia, M. Nelson, B. Gazzard, and M. Bower
The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 775-779; doi:10.1093/annonc/mdn697 [Abstract] [Full Text] [PDF] [Request Permissions]  

sarcomas Back

H. R. Kim, S. Y. Rha, S. H. Cheon, J. K. Roh, Y. N. Park, and N. C. Yoo
Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma
Annals of Oncology Advance Access published on January 29, 2009
Ann Oncol 2009 20: 780-787; doi:10.1093/annonc/mdn702 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor Back

P. Went, A. Zimpfer, A. Tzankov, and S. Dirnhofer
CD5 expression in de novo diffuse large B-cell lymphomas
Annals of Oncology Advance Access published on January 23, 2009
Ann Oncol 2009 20: 789-790; doi:10.1093/annonc/mdn793 [Extract] [Full Text] [PDF] [Request Permissions]  

S. Aksoy, N. Bulut, O. Dizdar, M. Tosur, A. Meral, and K. Altundag
Pathological characteristics of very young (≤30 years) breast cancer patients: a single-institution experience from Turkey
Annals of Oncology Advance Access published on January 27, 2009
Ann Oncol 2009 20: 790; doi:10.1093/annonc/mdn794 [Extract] [Full Text] [PDF] [Request Permissions]  

E. Vasile, C. Tibaldi, and A. Falcone
Is erlotinib really active after failure of gefitinib in advanced non-small-cell lung cancer patients?
Annals of Oncology Advance Access published on March 5, 2009
Ann Oncol 2009 20: 790-791; doi:10.1093/annonc/mdp013 [Extract] [Full Text] [PDF] [Request Permissions]  

C. Cacioppo, E. Morello, L. Casiraghi, R. Sandri, and S. Monfardini
Older cancer patients in an Italian hospice
Annals of Oncology Advance Access published on February 11, 2009
Ann Oncol 2009 20: 791-792; doi:10.1093/annonc/mdp014 [Extract] [Full Text] [PDF] [Request Permissions]  

C. Ferrario, A. Davidson, N. Bouganim, R. Aloyz, and L. C. Panasci
Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer
Annals of Oncology Advance Access published on February 17, 2009
Ann Oncol 2009 20: 792-795; doi:10.1093/annonc/mdp019 [Extract] [Full Text] [PDF] [Request Permissions]  

S. Dumitra, L. Sideris, Y. Leclerc, G. Leblanc, and P. Dubé
Neutropenic enterocolitis and docetaxel neoadjuvant chemotherapy
Annals of Oncology Advance Access published on March 10, 2009
Ann Oncol 2009 20: 795-796; doi:10.1093/annonc/mdp035 [Extract] [Full Text] [PDF] [Request Permissions]  

K. Okamoto, J. Tsurutani, M. Terashima, I. Okamoto, and K. Nakagawa
Zoledronic acid-induced regression of multiple metastases at nonskeletal sites
Annals of Oncology Advance Access published on March 5, 2009
Ann Oncol 2009 20: 796-797; doi:10.1093/annonc/mdp026 [Extract] [Full Text] [PDF] [Request Permissions]  

D. L. Nielsen, P. Pfeiffer, and B. V. Jensen
Six cases of treatment with panitumumab in patients with severe hypersensitivity reactions to cetuximab
Annals of Oncology Advance Access published on March 2, 2009
Ann Oncol 2009 20: 798; doi:10.1093/annonc/mdp040 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.